TMB-H

Clinical trials for TMB-H explained in plain language.

Never miss a new study

Get alerted when new TMB-H trials appear

Sign up with your email to follow new studies for TMB-H, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to shrink hard-to-treat tumors in 30-patient trial

Disease control Recruiting now

This study tests an experimental drug called IMC-001 in 30 adults whose advanced solid tumors have a high number of genetic mutations (TMB-H). The main goal is to see if the drug can shrink tumors. Researchers will also monitor side effects and how long the drug keeps the cancer …

Matched conditions: TMB-H

Phase: PHASE2 • Sponsor: ImmuneOncia Therapeutics Inc. • Aim: Disease control

Last updated Apr 30, 2026 15:51 UTC

TMB-H

Get alerted when new TMB-H trials appear

New drug aims to shrink hard-to-treat tumors in 30-patient trial